论文部分内容阅读
目的:探讨坦索罗辛联合托特罗定对于膀胱过度活动综合征的治疗效果。方法:本次研究选取我院门诊就治的82例膀胱过度活动综合征为研究对象,收治时间范围为2013.7~2015.9,依照随机数表法将上述患者均分为研究组和对照组,各包含41例病患。研究组患者采用坦索罗辛联合托特罗定,对照组采用单一托特罗定。对比临床效果。结果:研究组患者日均排尿次数为9.4次,日均单次尿量为154.9ml;对照组患者日均排尿次数为11.5次,日均单次尿量为363.8ml;对比后发现研究组患者在上述指标方面均显著优于对照组,差异具有显著统计学意义,P<0.01。结论:坦索罗辛联合托特罗定是一种有效治疗膀胱过度活动综合征的临床治疗方案。临床未见严重不良反应发生,值得临床广泛推广。
Objective: To investigate the effect of tamsulosin combined with tolterodine on overactive bladder syndrome. Methods: In this study, 82 cases of overactive bladder syndrome treated in our outpatient clinic were selected as the research object. The duration of treatment was from 2013.7 to 2015.9. According to the random number table, the above patients were divided into study group and control group, each containing 41 patients. Tamsulosin combined with tolterodine was used in the study group and single tolterodine was used in the control group. Comparison of clinical results. Results: The average number of urination in study group was 9.4 times and the average daily urine output was 154.9ml. In control group, the average number of urination was 11.5 times and the average daily urine output was 363.8ml. In the study group, The above indicators were significantly better than the control group, the difference was statistically significant, P <0.01. Conclusion: Tamsulosin combined with tolterodine is an effective clinical treatment of overactive bladder syndrome. No serious clinical adverse reactions occur, it is worth widely clinical promotion.